Abstract
To clarify the indication of percutaneous microwave coagulation therapy (PMCT) for hepatocellular carcinoma (HCC) as day surgery, we analyzed 43 patients who underwent PMCT.
These patients were divided into two groups : 14 patients who were performed PMCT in outpatients and 29 were in inpatients. We compared the clinicopathological features between the two groups retrospectively.
The liver function of outpatient group was better than of inpatient group. No patient that liver function had become worse after PMCT was seen even in inpatient group. For all outpatient group patients, PMCT could be done safely without severe complication. In effectiveness, there was no difference between two groups, but for large HCCs that were 2 cm or larger in diameter, it was worse in both groups.
Indeed day surgery PMCT was performed for selected patients with better liver function, but it could be done safely and the effectiveness compared similarly with inpatient group. So, day surgery PMCT should be selected as one of the treatment for HCC.
